On Monday, Terns Pharmaceuticals Inc (NASDAQ: TERN) was 6.56% up from the session before settling in for the closing price of $26.32. A 52-week range for TERN has been $1.87 – $28.49.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 16.38%. When this article was written, the company’s average yearly earnings per share was at 2.44%. With a float of $75.71 million, this company’s outstanding shares have now reached $87.51 million.
Terns Pharmaceuticals Inc (TERN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Terns Pharmaceuticals Inc stocks. The insider ownership of Terns Pharmaceuticals Inc is 15.96%, while institutional ownership is 81.68%. The most recent insider transaction that took place on Nov 04 ’25, was worth 441,360. In this transaction Director of this company sold 24,520 shares at a rate of $18.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 04 ’25, when Company’s Director proposed sale 24,520 for $14.03, making the entire transaction worth $344,016.
Terns Pharmaceuticals Inc (TERN) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.24 earnings per share (EPS) during the time that was better than consensus figure (set at -0.3) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.37% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
You can see what Terns Pharmaceuticals Inc (TERN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 19.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
The latest stats from [Terns Pharmaceuticals Inc, TERN] show that its last 5-days average volume of 3.77 million was superior to 1.57 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 83.02%.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 98.17%, which indicates a significant increase from 96.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.92 in the past 14 days, which was higher than the 0.72 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.45, while its 200-day Moving Average is $6.33. Now, the first resistance to watch is $28.83. This is followed by the second major resistance level at $29.62. The third major resistance level sits at $30.97. If the price goes on to break the first support level at $26.69, it is likely to go to the next support level at $25.34. Assuming the price breaks the second support level, the third support level stands at $24.55.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
There are 90,080K outstanding shares of the company, which has a market capitalization of 2.53 billion. As of now, sales total 0 K while income totals -88,850 K. Its latest quarter income was 0 K while its last quarter net income were -24,640 K.
